BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Nephrol. Dec 25, 2025; 14(4): 113300
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.113300
Table 2 Donor and immunology details

Total
PTDM
Control
P value
Total patients723240
Type of donor
Live donor66 (91.6)29 (90.6)37 (92.5)0.858
Deceased donor6 (8.3)3 (9.3)3 (7.5)
Distribution of live donor
Parent42 (58.3)17 (53.1)25 (62.5)0.865
Spouse18 (25.0)9 (28.1)9 (22.5)
Sibling3 (4.1)2 (6.2)1 (2.5)
Unrelated3 (4.1)1 (3.1)2 (2.5)
Number of HLA mismatch
13 (4.1)2 (6.2)1 (2.5)0.304
211 (15.2)5 (15.6)6 (15.0)
333 (45.8)11 (34.3)22 (40.0)
46 (8.3)3 (9.3)3 (7.5)
57 (9.7)3 (9.3)4 (10.0)
66 (8.3)5 (15.6)1 (2.5)
High PRA4 (5.5)2 (5.0)2 (5.0)0.815
Induction agent
No induction35 (48.6)13 (40.6)22 (55.0)0.297
Basiliximab26 (36.0)12 (37.5)14 (35.0)
ATG11 (15.2)7 (21.8)4 (10.0)


Write to the Help Desk